Amicus Therapeutics is a biotechnology company that develops and markets therapies for rare and orphan diseases, including treatments for Fabry and Pompe disease.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| George Soros / Soros Fund Mgmt | 30 | New buy | 5,000,000 | $71,200,000 | 0.8% |
| Bridgewater | 49 | New buy | 32,274 | $459,582 | 0.0% |
| Louis Bacon / Moore | 55 | New buy | 137,000 | $1,950,880 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.